Interobserver Agreement Rates on Fibroblast Activation Protein Inhibitor-Directed Molecular Imaging and Therapy

Sebastian E Serfling1, Philipp E Hartrampf1, Yingjun Zhi2

  • 1From the Department of Nuclear Medicine, University Hospital Würzburg.

Abstract

Insights

Interobserver agreement for 68Ga-FAPI-4 PET/CT interpretation and therapy decisions showed fair to good rates. This supports the clinical use of fibroblast activation protein inhibitor (FAPI)-directed imaging and endoradiotherapy (ERT).

Area of Science:

  • Oncology
  • Nuclear Medicine
  • Radiochemistry

Background:

  • Fibroblast activation protein (FAP) is a key target for novel cancer therapies.
  • FAP inhibitor (FAPI)-directed molecular imaging and endoradiotherapy (ERT) offer promising treatment avenues.
  • Accurate interpretation of 68Ga-FAPI-4 PET/CT is crucial for patient selection and treatment planning.

Purpose of the Study:

  • To evaluate the interobserver agreement in interpreting 68Ga-FAPI-4 PET/CT scans.
  • To assess agreement on decisions for FAPI-directed endoradiotherapy (ERT).
  • To determine the reliability of 68Ga-FAPI-4 PET/CT for clinical routine and multicenter trials.

Main Methods:

  • 49 oncology patients' 68Ga-FAPI-4 PET/CT scans were independently reviewed by 4 blinded readers.
  • Visual and quantitative assessments of scan findings, including metastases and affected regions, were performed.
  • Interobserver agreement was quantified using intraclass correlation coefficients (ICCs).

Main Results:

  • Fair agreement (ICC, 0.42) was observed for overall scan impression.
  • Good agreement rates (ICC, ≥0.63) were achieved for the number of lymph node metastases and organ metastases.
  • Fair agreement (ICC, 0.59) was noted for ERT decision-making.

Conclusions:

  • Fair to good interobserver agreement was achieved for 68Ga-FAPI-4 PET/CT interpretation and ERT decisions.
  • These findings support the integration of FAPI-directed molecular imaging and therapy into clinical practice.
  • The study validates the potential of 68Ga-FAPI-4 PET/CT for routine use and multicenter investigations.

Related Concept Videos